Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microplasmin for non-surgical treatment of focal vitreomacular adhesion
2008-004393-40Phase 3Completed
- Sponsor
- Oxurion
- Start
- Nov 2008
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in focal vitreomacular adhesion (VMA) and vitreomacular traction (VMT) comparing Microplasmin 125 µg with Placebo (2 arms). Primary endpoint: Nonsurgical resolution of focal vitreomacular adhesion at day 28. Started Nov 2008; status: completed.
02
Drugs
ocriplasmin
03
Conditions
focal vitreomacular adhesion (VMA)vitreomacular traction (VMT)
Beyond the preview
Go deeper on 2008-004393-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004393-40.